Last news
【2024 ASH】TransThera Announces the Phase I Study Results of TT-01488, a Novel Non-Covalent BTK Inhibitor, in Patients with Relapsed or Refractory B-cell Malignancies

【2024 ASH】TransThera Announces the Phase I Study Results of TT-01488, a Novel Non-Covalent BTK Inhibitor, in Patients with Relapsed or Refractory B-cell Malignancies

NANJING, China and GAITHERSBURG, Md., Dec. 10, 2024 /PRNewswire/ -- TransThera Sciences (Nanjing), Inc. (the "TransThera"), a clinical demand-oriented, registrational clinical stage biopharmaceutical company focusing on discovering and developing...

Bruce ATS™ Set to Launch: A New Era of Overnight Trading

Bruce ATS™ Set to Launch: A New Era of Overnight Trading

Leverages Nasdaq's advanced and trusted platform to offer market participants an industry-leading trading experience CHICAGO, Dec. 10, 2024 /PRNewswire/ -- PEAK6 Investments is excited to reveal plans for the launch of Bruce ATS, an Alternative...

Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...

Bybit Expands On-Chain Earn Offering with SUI Staking

Bybit Expands On-Chain Earn Offering with SUI Staking

DUBAI, UAE, Dec. 10, 2024 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, announces the addition of SUI to its On-Chain Earn platform, providing users the ability to participate in blockchain security...

Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety

Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...

Bybit Launches On-Chain Earn: Up to 3% APR with $cmETH and Guaranteed ETH Rewards

Bybit Launches On-Chain Earn: Up to 3% APR with $cmETH and Guaranteed ETH Rewards

DUBAI, UAE, Dec. 10, 2024 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is excited to announce the launch of its cmETH On-Chain Earn Party, offering users the opportunity to earn up to 3% APR by...

Young visitors savor Jiangsu's floral beauty mingled with economic prowess

Young visitors savor Jiangsu's floral beauty mingled with economic prowess

BEIJING, Dec. 10, 2024 /PRNewswire/ -- A news report from China Daily: During the tour the visitors got hands-on experience in making flower baskets. A group of young people, including those from seven countries beyond China, have witnessed up close...

Clarifai and Getty Images Announce Strategic Engagement to Make AI-Generated Images Available to Clarifai Customers

Clarifai and Getty Images Announce Strategic Engagement to Make AI-Generated Images Available to Clarifai Customers

Agreement Ensures AI-Generated Images Are Responsibly Sourced, Legally Protected, and Safe for Commercial Use WASHINGTON, Dec. 10, 2024 /PRNewswire/ -- Clarifai, a global leader in AI orchestration and development and pioneer of the full-stack...

menu
menu